NEO Neogenomics Inc

NeoGenomics Inc operates a network of cancer-related testing laboratories in Ft. Myers and Tampa, Florida; Irvine, California and Nashville, and Tennessee.

$48.10  +0.23 (0.48%)
As of 04/09/2021 15:59:59 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  01/23/2001
Outstanding shares:  117,048,193
Average volume:  962,030
Market cap:   $5,638,211,457
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    64049M209
ISIN:        US64049M2098
Sedol:      2598246
Valuation   (See tab for details)
PE ratio:   1,351.46
PB ratio:   7.78
PS ratio:   12.69
Return on equity:   0.60%
Net income %:   0.94%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy